DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Kshitij Polyline Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·13 Oct 2026, 6:15 am

Kshitij Polyline

Kshitij Polyline Limited has informed the stock exchanges that it has obtained a certificate under SEBI’s Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company has successfully completed the necessary formalities to maintain its status as a registered entity with the depositories.

This development is a routine administrative milestone for the company. For investors, it signifies that Kshitij Polyline is in full compliance with market regulations, ensuring the smooth processing of its securities and reducing the risk of regulatory hurdles in the future.

Investors should monitor the company’s future announcements for any updates on its financial performance or operational expansion plans, as these will be the primary drivers for the stock's valuation.